The molecular basis of the inhibition of HTLV-2 retroviral replication by the MHC class II transactivator (ClITA)

被引：0
|
作者：
Tosi, G
Pilotti, E
Barbaro, ADL
Mortara, L
Casoli, C
Accolla, RS
机构：
[1] Univ Insubria, Dept Clin & Biol Sci, Varese, Italy
[2] Univ Parma, Dept Clin Med Nephrol & Prevent, I-43100 Parma, Italy
来源：
TISSUE ANTIGENS | 2005年 / 66卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
2
引用
收藏
页码：343 / 343
页数：1
相关论文
共 50 条
  • [41] Control of in vitro immune responses by regulatory oligodeoxynucleotides through inhibition of pIII promoter directed expression of MHC class II transactivator in human primary monocytes
    Wang, Jinhai
    Roderiquez, Gregory
    Jones, Taneishia
    McPhie, Peter
    Norcross, Michael A.
    JOURNAL OF IMMUNOLOGY, 2007, 179 (01): : 45 - 52
  • [42] Structural basis of HLA-DO inhibition of HLA-DM catalyzed peptide exchange on MHC class II
    Guce, Abigail
    Mortimer, Sarah
    Mellins, Elizabeth
    Karlsson, Lars
    Stern, Lawrence
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [43] Engineering of novel Class II Transactivator gene delivery systems as molecular adjuvants to improve genetic immunotherapies by inducing de novo MHC II expression in human cells
    Palma, Mariana de Lucena
    Duangkhae, Parichat
    Douradinha, Bruno
    Dhalia, Rafael
    Mailliard, Robbie B.
    Barratt-Boyes, Simon
    Oshiro, Telma Miyuki
    Marques, Ernesto Torres de Azevedo
    Duarte, Alberto Jose da Silva
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [44] MOLECULAR-BASIS OF FUNCTIONAL BINDING OF THE SAME HIV PEPTIDE TO BOTH A CLASS-I AND A CLASS-II MHC MOLECULE
    BERZOFSKY, JA
    TAKESHITA, T
    TAKAHASHI, H
    KOZLOWSKI, S
    AHLERS, JD
    PENDLETON, CD
    MOORE, RL
    NAKAGAWA, Y
    YOKOMURO, K
    FOX, BS
    MARGULIES, DH
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 135 - 135
  • [45] Characterization of class II fumarase from Schistosoma mansoni provides the molecular basis for selective inhibition
    Cardoso, Iara Aime
    Luiz de Souza, Aline Kusumota
    Burgess, Adam Muslem George
    Chalmers, Iain Wyllie
    Hoffmann, Karl Francis
    Nonato, Maria Cristina
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2021, 175 : 406 - 421
  • [46] Deregulated MHC class II transactivator expression leads to a strong Th2 bias in CD4+ T lymphocytes
    Otten, LA
    Tacchini-Cottier, F
    Lohoff, M
    Annunziato, F
    Cosmi, L
    Scarpellino, L
    Louis, J
    Steimle, V
    Reith, W
    Acha-Orbea, H
    JOURNAL OF IMMUNOLOGY, 2003, 170 (03): : 1150 - 1157
  • [47] Down-Regulation of MHC Class II Expression through Inhibition of CIITA Transcription by Lytic Transactivator Zta during Epstein-Barr Virus Reactivation
    Li, Dan
    Qian, Lu
    Chen, Changguo
    Shi, Ming
    Yu, Ming
    Hu, Meiru
    Song, Lun
    Shen, Beifen
    Guo, Ning
    JOURNAL OF IMMUNOLOGY, 2009, 182 (04): : 1799 - 1809
  • [48] A BLOCK IN THE EXPRESSION OF MHC CLASS-II GENES AS THE MOLECULAR-BASIS FOR CONGENITAL IMMUNODEFICIENCY (BARE LYMPHOCYTE SYNDROME)
    DEPREVAL, C
    LOCHE, M
    GROSPIERRE, B
    GRISELLI, C
    HADAM, M
    MACH, B
    EXPERIENTIA, 1986, 42 (01): : 99 - 99
  • [49] Molecular basis for JAK2 inhibition with type II compounds.
    Jacome, Dafne
    Miao, Ya
    Haikarainen, Teemu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (23_SUPPL) : 176 - 176
  • [50] Molecular mechanisms of MHC class II inhibition by the MARCH1 ubiquitin ligase in response to IL-10
    Bourgeois-Daigneault, Marie-Claude
    Huppe, Gabrielle
    Tremblay, Jessy
    Steimle, Viktor
    Thibodeau, Jacques
    CYTOKINE, 2008, 43 (03) : 269 - 269
12345